Germans pay ever more for health care

18 May 2008

Germans are paying an ever higher annual sum towards the cost of their health care but the country's health service is increasingly being seen as a major creator of jobs and growth promoter in the national economy.

The federal statistical office, the SBA, has estimated the total health care bill for Germans and their health funds in 2006 at 245.0 billion euros ($379.28 billion), a rise of 2.4% over the previous year. This means that per capita health spending was 2,970 euros - 70 euros higher than the previous year. Health spending now accounts for nearly 11% of Gross Domestic Product, but still lags behind France and Switzerland.

While 57%, or 140.0 billion euros, of health spending for 2006 was down to the health funds - 3% up on the previous year - the level of spending on health in private households increased by 3.4% but has remained virtually unchanged as a proportion of total health spending, 14%, or 33.3 billion euros. Private health insurance accounts for almost 10% of total health care spending, or 22.5 billion euros.

This article is accessible to registered users, to continue reading please register for free.  A free trial will give you access to exclusive features, interviews, round-ups and commentary from the sharpest minds in the pharmaceutical and biotechnology space for a week. If you are already a registered user please login. If your trial has come to an end, you can subscribe here.

Login to your account

Become a subscriber

 

£820

Or £77 per month

Subscribe Now
  • Unfettered access to industry-leading news, commentary and analysis in pharma and biotech.
  • Updates from clinical trials, conferences, M&A, licensing, financing, regulation, patents & legal, executive appointments, commercial strategy and financial results.
  • Daily roundup of key events in pharma and biotech.
  • Monthly in-depth briefings on Boardroom appointments and M&A news.
  • Choose from a cost-effective annual package or a flexible monthly subscription
The Pharma Letter is an extremely useful and valuable Life Sciences service that brings together a daily update on performance people and products. It’s part of the key information for keeping me informed

Chairman, Sanofi Aventis UK







Today's issue

Company Spotlight